HomeNIRV • CNSX
add
Nirvana Life Sciences Inc
Previous close
$0.14
Year range
$0.030 - $0.50
Market cap
675.26K CAD
Avg Volume
185.00
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jul 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 45.86K | -7.86% |
Net income | -36.41K | 35.02% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jul 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.74K | -36.56% |
Total assets | 18.44K | -14.75% |
Total liabilities | 546.18K | -55.06% |
Total equity | -527.73K | — |
Shares outstanding | 22.82M | — |
Price to book | -7.00 | — |
Return on assets | -605.07% | — |
Return on capital | 12.65% | — |
Cash Flow
Net change in cash
| (CAD) | Jul 2025info | Y/Y change |
|---|---|---|
Net income | -36.41K | 35.02% |
Cash from operations | -955.15K | -86,652.77% |
Cash from investing | — | — |
Cash from financing | 954.22K | 18,016.86% |
Net change in cash | -933.00 | -184.74% |
Free cash flow | -919.82K | -5,022.22% |
About
Founded
2011
Headquarters
Website
Employees
2
